SOPHiA GENETICS SA Ordinary Shares (SOPH)

About SOPH

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through…

Sector

Technology

Industry

EDP Services

Employees

415

Website

www.sophiagenetics.com

Fundamentals

1-day range

$7.4$7.7

Market cap

$569.51M

P/E (trailing)

—

P/E (forward)

-15.00

EPS (trailing)

$-1.16

Dividend yield

—

Beta

0.92

Avg. volume

312.3K

Forecasts

4 analyst ratings

SOPHiA GENETICS SA Ordinary Shares Competitors

Chosen by industry and closest market cap.

• SOPH

  SOPHiA GENETICS SA Ordinary Shares

  $8.14

  ▼ 8.74%
  Market cap $569.51MP/E —
  $3.1$7.88
• YEXT

  Yext Inc. Common Stock

  $6.93

  ▲ 2.51%
  Market cap $558.38MP/E 14.46
  $3.27$9.2
• NRDS

  NerdWallet Inc. Class A Common Stock

  $9.91

  ▲ 2.16%
  Market cap $581.66MP/E 9.55
  $7.33$16.24
• OOMA

  Ooma Inc. Common Stock

  $22.89

  ▼ 0.65%
  Market cap $588.50MP/E 62.51
  $9.79$26.19
• OSPN

  OneSpan Inc. Common Stock

  $16.54

  ▲ 0.49%
  Market cap $598.48MP/E —
• IBEX

  IBEX Limited Common Shares

  $38.26

  ▲ 2.71%
  Market cap $494.86MP/E 10.25
  $25.94$42.99
• CARS

  Cars.com Inc. Common Stock

  $11.94

  ▲ 1.44%
  Market cap $669.41MP/E 24.10
  $7.4$13.97

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• SOPHiA GENETICS SA 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 8/5/2026
• HC Wainwright & Co. Maintains Buy on Sophia Genetics, Raises Price Target to $14
  Benzinga · 8/5/2026
• BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $9
  Benzinga · 8/5/2026
• SOPHiA GENETICS SA (SOPH) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/4/2026
• SOPHiA GENETICS (NASDAQ:SOPH) Beats Q2 Revenue Estimates, Shares Rise Despite Wider Loss
  ChartMill · 8/4/2026
• Sophia Genetics Raises FY2026 Sales Guidance from $92.000M-$94.000M to $94.000M-$96.000M vs $93.403M Est
  Benzinga · 8/4/2026
• Sophia Genetics Q2 EPS $(0.30) Misses $(0.20) Estimate, Sales $23.310M Beat $21.729M Estimate
  Benzinga · 8/4/2026
• SOPHiA GENETICS Announces Global Collaboration To Develop, Validate, And Deploy Two Companion Diagnostics Supporting Precision Oncology Therapies With AstraZeneca
  Benzinga · 8/4/2026

• Abhimanyu Verma · August 4, 2026 · Sale

  5.0K @ $6.95
• Jurgi Camblong · August 4, 2026 · Sale

  20.0K @ $6.92
• Zhenyu Xu · August 4, 2026 · Sale

  10.0K @ $6.92
• Philippe Menu · July 27, 2026 · Sale

  5.0K @ $5.66
• Jurgi Camblong · July 21, 2026 · Sale

  20.0K @ $6.63
• Jurgi Camblong · July 20, 2026 · Option Exercise

  4.6K @ $3.16
• Jurgi Camblong · July 20, 2026 · Sale

  4.6K @ $6.17
• Jurgi Camblong · July 20, 2026 · Sale

  19.8K @ $6.32
• Philippe Menu · July 13, 2026 · Sale

  5.0K @ $5.7
• Zhenyu Xu · July 13, 2026 · Sale

  4.0K @ $5.7
• Jurgi Camblong · July 10, 2026 · Sale

  8.5K @ $5.62
• Jurgi Camblong · July 7, 2026 · Sale

  17.7K @ $5.28
• Manuela Valente · July 6, 2026 · Sale

  4.2K @ $5.05
• Abhimanyu Verma · July 6, 2026 · Sale

  5.3K @ $5.1
• Zhenyu Xu · July 6, 2026 · Sale

  7.4K @ $5.17